Page last updated: 2024-10-31

metoprolol and Bone Cancer

metoprolol has been researched along with Bone Cancer in 2 studies

Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.

Research Excerpts

ExcerptRelevanceReference
"Adenylate cyclase activity in all Ewing's sarcomas was enhanced by GTP and NaF."1.27beta-Adrenergic receptors in pediatric tumors: uncoupled beta 1-adrenergic receptor in Ewing's sarcoma. ( Burdsall, J; Hollinger, B; Neely, J; Whitsett, JA; Workman, L, 1983)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Posielski, NM1
Richards, KA1
Liou, JI1
Borza, T1
Abel, EJ1
Downs, TM1
Jarrard, DF1
Whitsett, JA1
Burdsall, J1
Workman, L1
Hollinger, B1
Neely, J1

Other Studies

2 other studies available for metoprolol and Bone Cancer

ArticleYear
Beta-Adrenergic Antagonists and Cancer Specific Survival in Patients With Advanced Prostate Cancer: A Veterans Administration Cohort Study.
    Urology, 2021, Volume: 155

    Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Aged, 80 and over; Androgen Antagonists; Bone Neoplasm

2021
beta-Adrenergic receptors in pediatric tumors: uncoupled beta 1-adrenergic receptor in Ewing's sarcoma.
    Journal of the National Cancer Institute, 1983, Volume: 71, Issue:4

    Topics: Adenylyl Cyclases; Adrenergic beta-Antagonists; Animals; Binding, Competitive; Bone Neoplasms; Cell

1983